OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-55 Cr | ₹-9.59 Cr | ₹-7.89 Cr | ₹1.50 Cr | ₹-1.55 Cr |
What is the latest Net Current Assets ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹-55 Cr |
| Mar2024 | ₹-9.59 Cr |
| Mar2023 | ₹-7.89 Cr |
| Mar2022 | ₹1.50 Cr |
| Mar2021 | ₹-1.55 Cr |
How is Net Current Assets of OXYGENTA PHARMACEUTICAL Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹-55 Cr | Negative | |
| Mar2024 | ₹-9.59 Cr | Negative | |
| Mar2023 | ₹-7.89 Cr | Negative | |
| Mar2022 | ₹1.50 Cr | Positive | |
| Mar2021 | ₹-1.55 Cr | - | |
Compare Net Current Assets of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹195.1 Cr | -19.2% | -13.2% | -36.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,363.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,193.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,519.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,940.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -19.2% |
-13.2% |
-36.3% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses